Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
KALA PHARMACTCLS RG (NQ: KALA)
13.94 USD  +0.01 (+0.07%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jun 21, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 285,889
Open 13.91
Bid (Size) 10.15 (100)
Ask (Size) 16.40 (40000)
Prev. Close 13.93
Today's Range 13.80 - 14.95
52wk Range 11.81 - 26.75
Shares Outstanding 24,562,400
Dividend Yield N/A
Performance
YTD
-26.55%
-26.55%
1 Month
-5.75%
-5.75%
3 Month
-17.66%
-17.66%
6 Month
-19.89%
-19.89%
1 Year
-24.61%
-24.61%
Top News
More News
Market Trends Toward New Normal in Meredith, Weis Markets, Kala Pharmaceuticals, Fortress Transportation and Infrastructure Investors, Kraton, and Web.com Group — Emerging Consolidated Expectations, A
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Meredith Corporation... Read More
from GlobeNewswire News Releases
Kala Pharmaceuticals Announces Update to KPI-121 0.25% Development Plan
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today provided an update on the development plan for KPI-121 0.25%, which if approved could be the first FDA-approved product for the short-term treatment of... Read More
from Business Wire News Releases
More News
Read More
Kala Pharmaceuticals Reports First Quarter 2018 Financial Results
from Business Wire News Releases
Recent Analysis Shows Welltower, Integer, Jernigan Capital, ZTO EXPRESS INC, Kala Pharmaceuticals, and Covenant Transportation Group Market Influences — Renewed Outlook, Key Drivers of Growth
from GlobeNewswire News Releases
Kala Pharmaceuticals Strengthens Commercial Organization in Preparation for First Product Launch
from Business Wire News Releases
Kala Pharmaceuticals to Present at Upcoming Investor Conferences
from Business Wire News Releases
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
from Business Wire News Releases
Kala Pharmaceuticals to Present at the 2018 American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) and at the Ophthalmology Innovation Summit at ASCRS
from Business Wire News Releases
Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary
from Business Wire News Releases
Notable Tuesday Option Activity: SUPN, KALA, EQIX
category Stocks
from Market News Video
Analysts Forecast 25% Upside For The Holdings of IBB
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.